Tag: thursday-halozyme
-
Halozyme’s pancreatic cancer drug succeeds in mid-stage trial
(Reuters) – Halozyme Therapeutics Inc said its flagship drug delivery technology in tandem with therapies from Celgene Corp and Eli Lilly and Co succeeded in a mid-stage study involving patients with an advanced form of pancreatic cancer. Shares of Halozyme were up 47.3 percent at $15.77 in trading before the opening bell on Thursday. Halozyme’s…